🇺🇸 FDA
Pipeline program

VX-147

VX21-147-301

Phase 3 small_molecule active

Quick answer

VX-147 for Proteinuric Kidney Disease is a Phase 3 program (small_molecule) at VERTEX PHARMACEUTICALS INC / MA with 1 ClinicalTrials.gov record(s).

Program details

Company
VERTEX PHARMACEUTICALS INC / MA
Indication
Proteinuric Kidney Disease
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials